Role of activated protein C in the pathophysiology of severe sepsis

American Journal of Critical Care

Volumn 12, Issue 6, 2003, Pages 518-526

  Dettenmeier, Patricia ^a   Swindell, Bridget ^b   Stroud, Mary ^b   Arkins, Nancy ^c   Howard, April ^d  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE ANTIBODY; DROTRECOGIN; ENDOTOXIN ANTIBODY; PROTEIN C; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; RECOMBINANT PROTEIN;

ANTIMICROBIAL THERAPY; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG CONTRAINDICATION; FIBRINOLYSIS; HUMAN; INFLAMMATION; MEDICAL RESEARCH; PATHOPHYSIOLOGY; REVIEW; SEPSIS; SURGICAL TECHNIQUE; CHEMICALLY INDUCED DISORDER; HOSPITALIZATION; PATHOLOGY;

ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; HEMORRHAGE; HUMANS; PROTEIN C; RECOMBINANT PROTEINS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 7544228573     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2003.12.6.518     Document Type: Review

References (20)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310.
2. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;340:207-214.
3. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997;112:235-243.
4. Corrigan JJ, Ray WL, May N. Changes in the blood coagulation system associated with septicemia. N Engl J Med. 1968;279:851-856.
5. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-592.
6. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:1471-1477.
7. van Deventer SJH, Bluller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 1990;76:2520-2528.
8. Asaka S, Shibayama Y, Nakata K. Pathogenesis of focal and random hepatocellular necrosis in endotoxemia: microscopic observation in vivo. Liver. 1996;16:183-187.
9. Bajzar L. Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway. Arterioscler Thromb Vasc Biol. 2000;20:2511-2518.
10. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 1989;264:4743-4746.
11. Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345:408-416.
12. Yan SB, Dhainaut J-F. Activated protein C versus protein C in severe sepsis. Crit Care Med. 2001;29(7 suppl):S69-S74.
13. Fourrier F, Jourdain M, Tournois A, Caron C, Goudemand J, Chopin C. Coagulation inhibitor substitution during sepsis. Intensive Care Med. 1995;21(suppl 2):S264-S268.
14. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644-1655.
15. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
16. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.
17. Marshall JC. Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med. 2000;26(suppl 1):S75-S83.
18. Hancock WW, Bach FH. Immunobiology and therapeutic applications of protein C/protein S/thrombomodulin in human and experimental allotransplantation and xenotransplantation. Trends Cardiovasc Med. 1997;7:174-183.
19. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987;79:918-925.
20. Siegel JP. Assessing the use of activated protein C in the treatment of severe sepsis. N Engl J Med. 2002;347:1030-1034.